大会首页
关于大会
同期活动
演讲嘉宾
历届回顾
参展申请
展商中心
场馆介绍
联系我们
 
 
演讲嘉宾
 
徐寒梅教授
In 2004, Dr. Hanmei Xu joined the Department of Marine Pharmacy at China Pharmaceutical University. Since then, she designed a series antitumor peptides, including HM-3, Ap25 and EDSM. This work has the potential to lead to development of novel therapeutic drugs for cancer in China. Currently, Dr. Hanmei Xu and her research team have completed all the preclinical research of HM-3. As the principal investigator, her project was funded by the National Natural Science Foundation of China, the National High Technology Research and Development Program of China (863 Program), and  pharmaceutical company.
She was awarded with the honorable titles of Outstanding Young Teachers in Higher Education Institutions of Jiangsu Province. On Team Construction of Outstanding Innovative Talents, she has been awarded the Prize of “outstanding Innovative Talents of Inner Mengolia”. Dr. Xu’s work was highly appraised by Prof. of Chicago Medical Center.

Dr. Hanmei Xu has published more than 50 scientific papers since 2005, and holds 22 patents, She has trained more than 30 graduate students.

第八届国际生物医药产业发展创新论坛